O-linked β-N-acetylglucosaminidase inhibitor attenuates β-amyloid plaque and rescues memory impairment.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Neurobiology of Aging

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.neurobiolaging.2012.03.001PMID 22503002
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ghrelin Ameliorates Cognitive Dysfunction and Neurodegeneration in Intrahippocampal Amyloid-β1-42 Oligomer-Injected Mice

  2011cited by this paper
• O-GlcNAcylation increases non-amyloidogenic processing of the amyloid-β precursor protein (APP)

  2011cited by this paper
• FK506 Reduces Amyloid Plaque Burden and Induces MMP-9 in AβPP/PS1 Double Transgenic Mice

  2010cited by this paper
• Elevation of Global O-GlcNAc in Rodents Using a Selective O-GlcNAcase Inhibitor Does Not Cause Insulin Resistance or Perturb Glucohomeostasis

  2010cited by this paper
• Inhibition of O-GlcNAcase Using a Potent and Cell-Permeable Inhibitor Does Not Induce Insulin Resistance in 3T3-L1 Adipocytes

  2010cited by this paper
• O-linked beta-N-acetylglucosamine (O-GlcNAc): Extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stress.

  2010cited by this paper
• Inhibition of O-GlcNAcase Using a Potent and Cell-Permeable Inhibitor Does Not Induce Insulin Resistance in 3T3-L1 Adipocytes

  2010cited by this paper
• In Vivo Modulation of O-GlcNAc Levels Regulates Hippocampal Synaptic Plasticity through Interplay with Phosphorylation*

  2009cited by this paper
• Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model.

  2009cited by this paper
• A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo.

  2008cited by this paper
• Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease

  2008cited by this paper
• DNA damage-inducing agent-elicited γ-secretase activity is dependent on Bax/Bcl-2 pathway but not on caspase cascades

  2007cited by this paper
• Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation

  2006cited by this paper
• Thermal and UV shape shifting of surface topography.

  2006cited by this paper
• Intracerebral streptozotocin model of type 3 diabetes: Relevance to sporadic Alzheimer's disease

  2006cited by this paper
• Nicastrin functions as a gamma-secretase-substrate receptor.

  2005cited by this paper
• Nicastrin: gatekeeper of the gamma-secretase complex.

  2005cited by this paper
• O-GlcNAcase Uses Substrate-assisted Catalysis

  2005cited by this paper
• Nicastrin Functions as a γ-Secretase-Substrate Receptor

  2005cited by this paper
• The gamma-secretase complex: machinery for intramembrane proteolysis.

  2004cited by this paper
• The γ-secretase complex: machinery for intramembrane proteolysis

  2004cited by this paper
• Characterization of plasma inhibin forms in fertile and infertile men.

  2003cited by this paper
• The Transmembrane Domain Region of Nicastrin Mediates Direct Interactions with APH-1 and the γ-Secretase Complex*

  2003cited by this paper
• Partial purification and characterization of gamma-secretase from post-mortem human brain.

  2003cited by this paper
• Regulated hyperaccumulation of presenilin-1 and the "gamma-secretase" complex. Evidence for differential intramembranous processing of transmembrane subatrates.

  2003cited by this paper
• Partial Purification and Characterization of γ-Secretase from Post-mortem Human Brain*

  2003cited by this paper
• Identification of Novel Sites of O-N-Acetylglucosamine Modification of Serum Response Factor Using Quadrupole Time-of-flight Mass Spectrometry*

  2003cited by this paper
• The neurobiological basis of spontaneous alternation.

  2002cited by this paper
• A Sensitive and Quantitative Assay for Measuring Cleavage of Presenilin Substrates*

  2002cited by this paper
• Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes

  2002cited by this paper
• Co-expression of multiple transgenes in mouse CNS: a comparison of strategies.

  2001cited by this paper
• Glycosylation of Nucleocytoplasmic Proteins: Signal Transduction and O-GlcNAc

  2001cited by this paper
• Effect of cyclosporin A or tacrolimus on the function of blood-brain barrier cells.

  1999cited by this paper
• Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein

  1998cited by this paper
• Dynamic Glycosylation of Nuclear and Cytosolic Proteins

  1997cited by this paper
• β‐Amyloid precursor protein is modified with O‐linked N‐acetylglucosamine

  1995cited by this paper
• Production of the Alzheimer amyloid beta protein by normal proteolytic processing.

  1992cited by this paper
• Cortical Glutaminase, β-Glucuronidase and Glucose Utilization in Alzheimer's Disease

  1989cited by this paper

• Pharmacological inhibition of O-GlcNAcase reduces pS129-α-synuclein positive aggregates in the substantia nigra of mThy1-hSNCA mice.

  2026cites this paper
• Golgi Fragmentation as a Potential Link Between SARS-CoV-2 Infection and Alzheimer's Disease: Mechanisms and Implications for Neurodegeneration in Long COVID.

  2026cites this paper
• Transcript‐Level Modulation of O‐GlcNAc Transferase for Aging‐Related Neurodegenerative Diseases

  2026cites this paper
• Glycosylation in neuroinflammation: mechanisms, implications, and therapeutic strategies for neurodegenerative diseases

  2025cites this paper
• O-GlcNAc cycling in neuroinflammation: From molecular mechanisms and therapeutic perspectives.

  2025cites this paper
• Protein O‐GlcNAcylation in Health and Diseases

  2025cites this paper
• Pharmacologically increasing O-GlcNAcylation increases complexity of astrocytes in the dentate gyrus of TgF344-AD rats

  2025cites this paper
• NEU1-Mediated Extracellular Vesicle Glycosylation in Alzheimer’s Disease: Mechanistic Insights into Intercellular Communication and Therapeutic Targeting

  2025cites this paper
• Enhancing protein O-GlcNAcylation in down syndrome mice mitigates memory dysfunctions through the rescue of mitochondrial bioenergetics, stress responses and pathological markers

  2025cites this paper
• Triptolide induces the secretion of insulin, through which it alleviates the tauopathies of Alzheimer's disease via inhibiting the phosphorylation of tau.

  2025cites this paper
• Decoding Glycosylation in Neurodegenerative Diseases: Mechanistic Insights and Therapeutic Opportunities

  2025cites this paper
• Tissue-specific O-GlcNAcylation profiling identifies substrates in translational machinery in Drosophila mushroom body contributing to olfactory learning

  2024cites this paper
• Opportunities for Therapeutic Modulation of O-GlcNAc

  2024cites this paper
• The Potential Role of Artemisinins Against Neurodegenerative Diseases.

  2024cites this paper
• Glycosylation: mechanisms, biological functions and clinical implications

  2024cites this paper
• Golgi defect as a major contributor to lysosomal dysfunction

  2024cites this paper
• Protective effect of increased O-GlcNAc cycling against 6-OHDA induced Parkinson’s disease pathology

  2024cites this paper
• Emerging roles of O-GlcNAcylation in protein trafficking and secretion.

  2024cites this paper
• Dessert or Poison? The Roles of Glycosylation in Alzheimer's, Parkinson's, Huntington's Disease, and Amyotrophic Lateral Sclerosis

  2023cites this paper
• Deciphering the Properties and Functions of Glycoproteins Using Quantitative Proteomics

  2023cites this paper
• O‐GlcNAcylation: cellular physiology and therapeutic target for human diseases

  2023cites this paper
• Understanding and exploiting the roles of O-GlcNAc in neurodegenerative diseases

  2023cites this paper
• Enhanced production of N-acetyl-glucosaminidase by marine Aeromonas caviae CHZ306 in bioreactor

  2023cites this paper
• Hexosamine Biosynthetic Pathway and O-GlcNAc cycling of Glucose Metabolism in Brain Function and Disease.

  2023cites this paper
• O-GlcNAc Dynamics: The Sweet Side of Protein Trafficking Regulation in Mammalian Cells

  2023cites this paper
• Mechanistic and Etiological Similarities in Diabetes Mellitus and Alzheimer's Disease: Antidiabetic Drugs as Optimistic Therapeutics in Alzheimer's Disease.

  2022cites this paper
• Diverse pathways to neuronal necroptosis in Alzheimer's disease

  2022cites this paper
• Integration of O-GlcNAc into Stress Response Pathways

  2022cites this paper
• Altered O-GlcNAcylation and mitochondrial dysfunction, a molecular link between brain glucose dysregulation and sporadic Alzheimer’s disease

  2022cites this paper
• Clinical relevance of biomarkers, new therapeutic approaches, and role of post-translational modifications in the pathogenesis of Alzheimer’s disease

  2022cites this paper
• Coenzyme A-Dependent Tricarboxylic Acid Cycle Enzymes Are Decreased in Alzheimer’s Disease Consistent With Cerebral Pantothenate Deficiency

  2022cites this paper
• Monitoring and modulating O-GlcNAcylation: assays and inhibitors of O-GlcNAc processing enzymes.

  2021cites this paper
• Increased O-GlcNAcylation of Drp1 by amyloid-beta promotes mitochondrial fission and dysfunction in neuronal cells

  2021cites this paper
• O-GlcNAcylation Inhibits Endocytosis of Amyloid Precursor Protein by Decreasing Its Localization in Lipid Raft Microdomains

  2021cites this paper
• O-GlcNAcylation in health and neurodegenerative diseases

  2021cites this paper
• REM Sleep Deprivation Impairs Learning and Memory by Decreasing Brain O-GlcNAc Cycling in Mouse

  2021cites this paper
• Mechanistic roles for altered O-GlcNAcylation in neurodegenerative disorders.

  2021cites this paper
• Repeated hypoxia exposure induces cognitive dysfunction, brain inflammation, and amyloidβ/p-Tau accumulation through reduced brain O-GlcNAcylation in zebrafish

  2021cites this paper
• Therapies for Alzheimer's disease: a metabolic perspective.

  2021cites this paper
• O-GlcNAcylation ameliorates the pathological manifestations of Alzheimer’s disease by inhibiting necroptosis

  2021cites this paper
• Implications of Glycosylation in Alzheimer’s Disease

  2021cites this paper
• Analytical and Biochemical Perspectives of Protein O-GlcNAcylation.

  2021cites this paper
• Fluctuation in O-GlcNAcylation inactivates STIM1 to reduce store-operated calcium ion entry via down-regulation of Ser621 phosphorylation.

  2020cites this paper
• O-GlcNAcylation regulates dopamine neuron function, survival and degeneration in Parkinson disease

  2020cites this paper
• The Dysregulation of OGT/OGA Cycle Mediates Tau and APP Neuropathology in Down Syndrome

  2020cites this paper
• The Glucose Metabolic Pathway as A Potential Target for Therapeutics: Crucial Role of Glycosylation in Alzheimer’s Disease

  2020cites this paper
• O‐GlcNAcase: Emerging Mechanism, Substrate Recognition and Small‐Molecule Inhibitors

  2020cites this paper
• Pharmacological inhibition and knockdown of O‐GlcNAcase reduces cellular internalization of α‐synuclein preformed fibrils

  2020cites this paper
• PET quantification of brain O-GlcNAcase with [18F]LSN3316612 in healthy human volunteers

  2020cites this paper
• Chronic hyperglycemia induces tau hyperphosphorylation by downregulating OGT-involved O-GlcNAcylation in vivo and in vitro.

  2020cites this paper
• O-GlcNAcylation as a Therapeutic Target for Alzheimer’s Disease

  2020cites this paper
• Targeting O-GlcNAcylation to develop novel therapeutics.

  2020cites this paper
• Glucose transporters in brain in health and disease

  2020cites this paper
• Role of O-Linked N-acetylglucosamine (O-GlcNAc) Protein Modification in Cellular (Patho)Physiology.

  2020cites this paper
• Pharmacological Inhibition of O-GlcNAc Transferase Promotes mTOR-Dependent Autophagy in Rat Cortical Neurons

  2020cites this paper
• Fluctuation in O-GlcNAcylation inactivates STIM1 to reduce store-operated calcium ion entry via down-regulation of Ser621 phosphorylation

  2020cites this paper
• Modulation of O-GlcNAcylation Regulates Autophagy in Cortical Astrocytes

  2019cites this paper
• Diminished O-GlcNAcylation in Alzheimer's disease is strongly correlated with mitochondrial anomalies.

  2019cites this paper
• Increased Ratio of Global O-GlcNAcylation to Tau Phosphorylation at Thr212 Site Is Associated With Better Memory Function in Patients With Type 2 Diabetes

  2019cites this paper
• O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.

  2019cites this paper
• Molecular Connection Between Diabetes and Dementia.

  2019cites this paper
• The Role of Insulin Resistance and Protein O-GlcNAcylation in Neurodegeneration

  2019cites this paper
• O-GlcNAcylation, a sweet link to the pathology of diseases

  2019cites this paper
• O-GlcNAcylation of Amyloid-β Protein Precursor by Insulin Signaling Reduces Amyloid-β Production

  2019cites this paper
• CA-30, an oligosaccharide fraction derived from Liuwei Dihuang decoction, ameliorates cognitive deterioration via the intestinal microbiome in the senescence-accelerated mouse prone 8 strain

  2019cites this paper
• Role of Post‐translational Modifications in Alzheimer's Disease

  2019cites this paper
• Deciphering the Functions of O-GlcNAc Glycosylation in the Brain: The Role of Site-Specific Quantitative O-GlcNAcomics.

  2018cites this paper
• Amyloid β‐induced elevation of O‐GlcNAcylated c‐Fos promotes neuronal cell death

  2018cites this paper
• Centella asiatica attenuates hippocampal mitochondrial dysfunction and improves memory and executive function in &bgr;‐amyloid overexpressing mice

  2018cites this paper
• Proteomic identification of altered protein O-GlcNAcylation in a triple transgenic mouse model of Alzheimer's disease.

  2018cites this paper
• Nutrient‐driven O‐GlcNAc in proteostasis and neurodegeneration

  2018cites this paper
• Investigating the neuroprotective role of OGA inhibition by Thiamet-G against Alzheimer\'s disease

  2018influential citation
• Selective inhibition of β-N-acetylhexosaminidases by thioglycosyl-naphthalimide hybrid molecules.

  2018cites this paper
• Pharmacological Inhibition of O-GlcNAcase Enhances Autophagy in Brain through an mTOR-Independent Pathway.

  2018cites this paper
• O-GlcNAcase Fragment Discovery with Fluorescence Polarimetry.

  2018cites this paper
• O-GlcNAcylation and neuronal energy status: Implications for Alzheimer's disease.

  2018cites this paper
• O-GlcNAc cycling in the developing, adult and geriatric brain

  2018cites this paper
• The emerging link between O-GlcNAcylation and neurological disorders

  2017cites this paper
• The Essential Role of O-GlcNAcylation in Primary Sensory Neurons

  2017cites this paper
• Evaluation of the Chemical Reporter Analog PNP-6AzGlcNAc as an O-GlcNAcase Substrate

  2017cites this paper
• Utilising the MultiBac expression system to reconstruct and purify the gamma secretase enzyme

  2017cites this paper
• Memory and synaptic plasticity are impaired by dysregulated hippocampal O-GlcNAcylation

  2017cites this paper
• Carb cutting works better with a partner

  2017cites this paper
• O-GlcNAcylation and neurodegeneration.

  2017cites this paper
• In Vitro Biochemical Assays for O‐GlcNAc‐Processing Enzymes

  2017cites this paper
• Roles of O-GlcNAc in chronic diseases of aging.

  2016cites this paper
• Diabetes and Alzheimer's disease crosstalk.

  2016cites this paper
• N-Adamantyl-4-methylthiazol-2-amine suppresses amyloid β-induced neuronal oxidative damage in cortical neurons

  2016cites this paper
• O‐GlcNAcylation: A regulator of tau pathology and neurodegeneration

  2016cites this paper
• Loss of O-GlcNAc glycosylation in forebrain excitatory neurons induces neurodegeneration

  2016influential citation
• O‐GlcNAcylation of protein kinase A catalytic subunits enhances its activity: a mechanism linked to learning and memory deficits in Alzheimer's disease

  2016cites this paper
• Analysis of transition state mimicry by tight binding aminothiazoline inhibitors provides insight into catalysis by human O-GlcNAcase† †Electronic supplementary information (ESI) available: Detailed experimental procedures, NMR spectra and additional figures illustrating Ki graphs, kinetic data, pKa

  2016cites this paper
• Roles of O-GlcNAcylation on amyloid-β precursor protein processing, tau phosphorylation, and hippocampal synapses dysfunction in Alzheimer’s disease

  2016cites this paper
• Intracellular and extracellular O-linked N-acetylglucosamine in the nervous system.

  2015cites this paper
• O-GlcNAcylation Promotes Non-Amyloidogenic Processing of Amyloid-β Protein Precursor via Inhibition of Endocytosis from the Plasma Membrane

  2015cites this paper
• Mitochondrial ATP synthase activity is impaired by suppressed O-GlcNAcylation in Alzheimer's disease.

  2015cites this paper
• AGE-RELATED WEIGHT LOSS IN THE 5XFAD MOUSE MODEL OF ALZHEIMER’S DISEASE: A BEHAVIOURAL AND HORMONAL ANALYSIS

  2015influential citation
• Targeting Transcriptional Control of Fatty Acid Oxidation to Treat Heart Disease

  2014cites this paper
• The Emerging Link between O-GlcNAc and Alzheimer Disease*

  2014cites this paper
• Learning strategy preference of 5XFAD transgenic mice depends on the sequence of place/spatial and cued training in the water maze task.

  2014cites this paper